 John Repine
Concepts (726)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 118 | 2005 | 1233 | 4.740 |
Why?
| | Interleukin-1 | 32 | 2015 | 980 | 3.100 |
Why?
| | Xanthine Oxidase | 42 | 2003 | 80 | 2.980 |
Why?
| | Oxygen | 54 | 2016 | 854 | 2.960 |
Why?
| | Lung | 91 | 2013 | 3664 | 2.810 |
Why?
| | Hydrogen Peroxide | 48 | 2000 | 305 | 2.370 |
Why?
| | Rats | 100 | 2015 | 5392 | 1.600 |
Why?
| | Oxidative Stress | 12 | 2016 | 1178 | 1.500 |
Why?
| | Catalase | 41 | 1997 | 123 | 1.490 |
Why?
| | Antioxidants | 13 | 2012 | 564 | 1.310 |
Why?
| | Superoxides | 28 | 1999 | 221 | 1.290 |
Why?
| | Thiourea | 29 | 1995 | 38 | 1.200 |
Why?
| | Pulmonary Edema | 23 | 1997 | 125 | 1.190 |
Why?
| | Macrophages, Alveolar | 4 | 2016 | 359 | 1.170 |
Why?
| | Rats, Sprague-Dawley | 37 | 2015 | 2478 | 1.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 14 | 2016 | 613 | 1.030 |
Why?
| | Animals | 171 | 2016 | 33381 | 1.020 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2016 | 124 | 1.000 |
Why?
| | Endothelium, Vascular | 15 | 2002 | 907 | 0.930 |
Why?
| | Xanthine Dehydrogenase | 14 | 1999 | 34 | 0.910 |
Why?
| | Ergothioneine | 2 | 2012 | 2 | 0.860 |
Why?
| | Lipopolysaccharides | 7 | 2015 | 870 | 0.810 |
Why?
| | Ferritins | 4 | 2004 | 61 | 0.800 |
Why?
| | Blood Bactericidal Activity | 20 | 1992 | 37 | 0.770 |
Why?
| | Interferon Type I | 1 | 2021 | 129 | 0.740 |
Why?
| | Glutathione | 19 | 2000 | 324 | 0.740 |
Why?
| | Prostaglandins | 3 | 2019 | 78 | 0.720 |
Why?
| | Reperfusion Injury | 15 | 1997 | 276 | 0.710 |
Why?
| | In Vitro Techniques | 45 | 1996 | 1094 | 0.700 |
Why?
| | Ischemia | 11 | 1997 | 374 | 0.700 |
Why?
| | Persian Gulf Syndrome | 1 | 2019 | 9 | 0.700 |
Why?
| | Chemokines, CXC | 6 | 2005 | 64 | 0.690 |
Why?
| | Leukotrienes | 1 | 2019 | 35 | 0.690 |
Why?
| | Enzyme Inhibitors | 8 | 2004 | 827 | 0.690 |
Why?
| | Free Radicals | 24 | 2008 | 104 | 0.690 |
Why?
| | Virus Diseases | 1 | 2021 | 198 | 0.670 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 174 | 0.670 |
Why?
| | Pulmonary Alveoli | 23 | 2011 | 384 | 0.670 |
Why?
| | Dimethyl Sulfoxide | 18 | 1994 | 45 | 0.660 |
Why?
| | Superoxide Dismutase | 27 | 1996 | 339 | 0.650 |
Why?
| | Aerosols | 4 | 2016 | 221 | 0.640 |
Why?
| | Lung Injury | 9 | 2014 | 210 | 0.630 |
Why?
| | Capillary Permeability | 13 | 1998 | 140 | 0.620 |
Why?
| | Chemotactic Factors | 11 | 1997 | 51 | 0.620 |
Why?
| | Rats, Inbred Strains | 37 | 1992 | 394 | 0.620 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 367 | 0.620 |
Why?
| | Intercellular Signaling Peptides and Proteins | 6 | 2005 | 369 | 0.600 |
Why?
| | Cytokines | 8 | 2014 | 1900 | 0.600 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 331 | 0.600 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 1137 | 0.590 |
Why?
| | Oxidants | 6 | 2004 | 122 | 0.590 |
Why?
| | Staphylococcus aureus | 29 | 1988 | 394 | 0.580 |
Why?
| | Malathion | 1 | 2016 | 1 | 0.570 |
Why?
| | Chemotaxis, Leukocyte | 9 | 1997 | 133 | 0.560 |
Why?
| | Pneumonia | 5 | 2011 | 592 | 0.550 |
Why?
| | Tetradecanoylphorbol Acetate | 20 | 1994 | 155 | 0.540 |
Why?
| | Capillaries | 2 | 2015 | 103 | 0.540 |
Why?
| | Leukocyte Elastase | 5 | 2002 | 80 | 0.530 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 53 | 0.530 |
Why?
| | Macrophages | 24 | 1991 | 1324 | 0.530 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 55 | 0.530 |
Why?
| | Myocardial Reperfusion Injury | 9 | 1992 | 105 | 0.520 |
Why?
| | Respiration, Artificial | 3 | 2015 | 545 | 0.520 |
Why?
| | Glutamine | 1 | 2015 | 88 | 0.520 |
Why?
| | Kidney | 11 | 1999 | 1353 | 0.510 |
Why?
| | Phagocytosis | 22 | 2007 | 364 | 0.480 |
Why?
| | Hemorrhage | 4 | 2004 | 623 | 0.480 |
Why?
| | Lung Diseases | 10 | 2007 | 718 | 0.480 |
Why?
| | Prostaglandin D2 | 1 | 2013 | 23 | 0.470 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2015 | 298 | 0.470 |
Why?
| | Quinacrine | 3 | 2004 | 8 | 0.470 |
Why?
| | Male | 101 | 2019 | 57801 | 0.470 |
Why?
| | Neutrophil Infiltration | 1 | 2013 | 97 | 0.460 |
Why?
| | Hydroxides | 9 | 1991 | 26 | 0.460 |
Why?
| | Nitric Oxide | 8 | 2014 | 892 | 0.440 |
Why?
| | Antigens, CD | 1 | 2015 | 460 | 0.440 |
Why?
| | L-Lactate Dehydrogenase | 17 | 2013 | 112 | 0.440 |
Why?
| | Perfusion | 21 | 1998 | 153 | 0.430 |
Why?
| | Allopurinol | 11 | 2003 | 82 | 0.420 |
Why?
| | Myocardium | 14 | 1992 | 970 | 0.420 |
Why?
| | Pulmonary Artery | 13 | 1997 | 1063 | 0.410 |
Why?
| | Peroxidase | 14 | 2003 | 170 | 0.410 |
Why?
| | Inflammation | 6 | 2016 | 2566 | 0.410 |
Why?
| | Serine Proteinase Inhibitors | 4 | 2002 | 35 | 0.410 |
Why?
| | Cell Adhesion | 15 | 2007 | 443 | 0.410 |
Why?
| | Fruit | 1 | 2012 | 130 | 0.400 |
Why?
| | Vegetables | 1 | 2012 | 133 | 0.390 |
Why?
| | Burns | 4 | 2019 | 247 | 0.390 |
Why?
| | Aldehyde Oxidoreductases | 4 | 1999 | 32 | 0.390 |
Why?
| | Rabbits | 29 | 1991 | 780 | 0.390 |
Why?
| | Pancreatic Elastase | 8 | 1993 | 74 | 0.390 |
Why?
| | Tumor Necrosis Factor-alpha | 8 | 2005 | 1171 | 0.380 |
Why?
| | Tungsten | 15 | 2003 | 29 | 0.380 |
Why?
| | Reactive Oxygen Species | 5 | 1999 | 576 | 0.380 |
Why?
| | Pentoxifylline | 4 | 1997 | 22 | 0.380 |
Why?
| | Humans | 124 | 2021 | 118972 | 0.380 |
Why?
| | Cells, Cultured | 28 | 2008 | 4077 | 0.370 |
Why?
| | Pulmonary Circulation | 6 | 2005 | 424 | 0.370 |
Why?
| | Cattle | 18 | 2007 | 978 | 0.360 |
Why?
| | Oxidation-Reduction | 22 | 1999 | 940 | 0.360 |
Why?
| | Erythrocytes | 11 | 1995 | 641 | 0.350 |
Why?
| | Heart | 10 | 1994 | 631 | 0.350 |
Why?
| | Biomarkers | 9 | 2019 | 3588 | 0.340 |
Why?
| | Soot | 1 | 2008 | 22 | 0.330 |
Why?
| | Phorbols | 8 | 1986 | 10 | 0.330 |
Why?
| | Vitamin E | 4 | 1998 | 116 | 0.330 |
Why?
| | Tissue Plasminogen Activator | 3 | 2005 | 231 | 0.330 |
Why?
| | Oxygen Consumption | 19 | 1995 | 586 | 0.330 |
Why?
| | Dietary Supplements | 1 | 2012 | 467 | 0.320 |
Why?
| | Gulf War | 2 | 2019 | 8 | 0.320 |
Why?
| | Granulomatous Disease, Chronic | 12 | 1988 | 61 | 0.320 |
Why?
| | Dinoprost | 2 | 2019 | 31 | 0.310 |
Why?
| | Receptors, Interleukin-1 | 4 | 1997 | 228 | 0.310 |
Why?
| | Platelet Activating Factor | 3 | 2000 | 95 | 0.300 |
Why?
| | Tyrosine | 2 | 2008 | 233 | 0.300 |
Why?
| | Bacterial Infections | 7 | 1993 | 227 | 0.300 |
Why?
| | Phosphatidic Acids | 2 | 1997 | 9 | 0.290 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2007 | 175 | 0.290 |
Why?
| | Particulate Matter | 1 | 2008 | 244 | 0.290 |
Why?
| | Blood Platelets | 7 | 1992 | 369 | 0.280 |
Why?
| | Shock, Septic | 3 | 2000 | 187 | 0.280 |
Why?
| | Leukocytes | 7 | 2007 | 290 | 0.280 |
Why?
| | Free Radical Scavengers | 8 | 2000 | 88 | 0.280 |
Why?
| | Trachea | 6 | 2005 | 226 | 0.280 |
Why?
| | Endothelium | 10 | 1997 | 120 | 0.280 |
Why?
| | Phagocytes | 2 | 2003 | 91 | 0.270 |
Why?
| | Muscles | 3 | 1991 | 333 | 0.270 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 24 | 0.260 |
Why?
| | Administration, Inhalation | 5 | 2016 | 656 | 0.260 |
Why?
| | Recombinant Proteins | 10 | 2005 | 1308 | 0.260 |
Why?
| | Krypton | 3 | 2011 | 4 | 0.260 |
Why?
| | Leukotriene B4 | 3 | 2016 | 51 | 0.260 |
Why?
| | Obesity | 2 | 2015 | 2746 | 0.260 |
Why?
| | Tidal Volume | 2 | 2015 | 74 | 0.250 |
Why?
| | Endotoxins | 7 | 1992 | 234 | 0.250 |
Why?
| | Mitochondria | 5 | 2008 | 786 | 0.250 |
Why?
| | Postoperative Complications | 1 | 2015 | 2235 | 0.240 |
Why?
| | Growth Substances | 4 | 1997 | 136 | 0.240 |
Why?
| | Coronary Disease | 5 | 1991 | 356 | 0.240 |
Why?
| | Skin | 3 | 1995 | 657 | 0.240 |
Why?
| | Glutathione Peroxidase | 10 | 1994 | 54 | 0.240 |
Why?
| | Leukocyte Count | 8 | 2003 | 305 | 0.240 |
Why?
| | Acute Kidney Injury | 3 | 1997 | 709 | 0.240 |
Why?
| | Nitroblue Tetrazolium | 8 | 2000 | 10 | 0.230 |
Why?
| | Environmental Exposure | 2 | 2017 | 405 | 0.220 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2003 | 56 | 0.220 |
Why?
| | Smoking | 7 | 2014 | 1487 | 0.220 |
Why?
| | Organ Size | 10 | 1998 | 460 | 0.210 |
Why?
| | Amitrole | 8 | 1990 | 9 | 0.210 |
Why?
| | Particle Size | 3 | 2016 | 345 | 0.210 |
Why?
| | Edema | 4 | 1997 | 124 | 0.210 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 1945 | 0.210 |
Why?
| | Neutropenia | 5 | 1997 | 133 | 0.210 |
Why?
| | von Willebrand Factor | 3 | 2019 | 58 | 0.210 |
Why?
| | Thromboxanes | 4 | 1988 | 16 | 0.200 |
Why?
| | Risk Factors | 9 | 2019 | 9000 | 0.200 |
Why?
| | Glycine | 1 | 2002 | 162 | 0.200 |
Why?
| | Corneal Stroma | 1 | 2001 | 18 | 0.200 |
Why?
| | Photorefractive Keratectomy | 1 | 2001 | 13 | 0.200 |
Why?
| | Administration, Intranasal | 1 | 2021 | 79 | 0.200 |
Why?
| | Air Pollutants, Occupational | 1 | 2001 | 33 | 0.200 |
Why?
| | Sodium | 2 | 1999 | 200 | 0.190 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 462 | 0.190 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 1997 | 28 | 0.190 |
Why?
| | Renal Circulation | 4 | 1997 | 75 | 0.190 |
Why?
| | Nitrates | 2 | 2017 | 78 | 0.190 |
Why?
| | Acute Disease | 8 | 1999 | 940 | 0.180 |
Why?
| | Phagocyte Bactericidal Dysfunction | 5 | 1979 | 12 | 0.180 |
Why?
| | Indicators and Reagents | 6 | 2000 | 100 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 3 | 1995 | 495 | 0.180 |
Why?
| | Female | 32 | 2019 | 61564 | 0.180 |
Why?
| | Iron | 7 | 1997 | 248 | 0.180 |
Why?
| | Kinetics | 12 | 1996 | 1624 | 0.180 |
Why?
| | Chemokine CXCL1 | 4 | 2005 | 69 | 0.180 |
Why?
| | Sialoglycoproteins | 2 | 1997 | 162 | 0.170 |
Why?
| | Alcohol Dehydrogenase | 1 | 1999 | 22 | 0.170 |
Why?
| | Lactoferrin | 2 | 2017 | 29 | 0.170 |
Why?
| | Physical Exertion | 1 | 2000 | 222 | 0.170 |
Why?
| | Cell Count | 3 | 2013 | 315 | 0.170 |
Why?
| | Sulfonamides | 1 | 2002 | 445 | 0.170 |
Why?
| | Luminescent Measurements | 8 | 1997 | 72 | 0.170 |
Why?
| | Interleukin-8 | 3 | 1997 | 249 | 0.170 |
Why?
| | Multiple Trauma | 1 | 1999 | 97 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 200 | 0.160 |
Why?
| | Permeability | 6 | 2000 | 156 | 0.160 |
Why?
| | Brain Edema | 2 | 1990 | 61 | 0.160 |
Why?
| | Monocytes | 7 | 2007 | 513 | 0.160 |
Why?
| | Kidney Tubules, Proximal | 1 | 1999 | 131 | 0.160 |
Why?
| | Alprostadil | 2 | 1997 | 32 | 0.160 |
Why?
| | Molybdenum | 1 | 1997 | 9 | 0.160 |
Why?
| | Acetylcysteine | 3 | 1995 | 148 | 0.150 |
Why?
| | Lung Diseases, Obstructive | 1 | 1997 | 44 | 0.150 |
Why?
| | Veterans Health | 1 | 2019 | 167 | 0.150 |
Why?
| | Intubation, Intratracheal | 5 | 2000 | 226 | 0.150 |
Why?
| | Therapeutic Irrigation | 7 | 1997 | 67 | 0.150 |
Why?
| | Chronic Disease | 3 | 2014 | 1636 | 0.150 |
Why?
| | Phospholipases A | 1 | 1997 | 101 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 508 | 0.150 |
Why?
| | Polyethylene Glycols | 5 | 1990 | 578 | 0.150 |
Why?
| | Chromatography, Affinity | 1 | 1996 | 85 | 0.140 |
Why?
| | Neutrophil Activation | 1 | 1997 | 100 | 0.140 |
Why?
| | DNA Damage | 1 | 1999 | 357 | 0.140 |
Why?
| | Hypoxia | 3 | 2015 | 963 | 0.140 |
Why?
| | Sepsis | 2 | 2000 | 531 | 0.140 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1996 | 147 | 0.140 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1996 | 86 | 0.140 |
Why?
| | Carbonates | 1 | 1995 | 6 | 0.140 |
Why?
| | Menstruation | 2 | 1986 | 36 | 0.130 |
Why?
| | One-Lung Ventilation | 1 | 2015 | 2 | 0.130 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1996 | 167 | 0.130 |
Why?
| | Ethanol | 2 | 1999 | 575 | 0.130 |
Why?
| | Predictive Value of Tests | 5 | 2019 | 1868 | 0.130 |
Why?
| | Critical Care | 1 | 2000 | 492 | 0.130 |
Why?
| | Adjuvants, Immunologic | 1 | 1997 | 207 | 0.130 |
Why?
| | Pulmonary Surfactants | 3 | 2007 | 98 | 0.130 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 827 | 0.130 |
Why?
| | Mice, Inbred Strains | 1 | 2016 | 405 | 0.130 |
Why?
| | Sodium Bicarbonate | 1 | 1995 | 45 | 0.130 |
Why?
| | Vitamin E Deficiency | 1 | 1995 | 42 | 0.130 |
Why?
| | Vinblastine | 6 | 1997 | 68 | 0.130 |
Why?
| | Interleukin-10 | 1 | 1997 | 306 | 0.130 |
Why?
| | Glutathione Disulfide | 5 | 1994 | 29 | 0.130 |
Why?
| | Positive-Pressure Respiration | 1 | 2015 | 70 | 0.130 |
Why?
| | Muscle, Smooth, Vascular | 2 | 1997 | 454 | 0.130 |
Why?
| | Oligonucleotides | 1 | 1995 | 140 | 0.130 |
Why?
| | Carbon Dioxide | 2 | 1995 | 230 | 0.130 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1994 | 45 | 0.120 |
Why?
| | Case-Control Studies | 2 | 2019 | 3171 | 0.120 |
Why?
| | Reperfusion | 2 | 1992 | 43 | 0.120 |
Why?
| | Vasoconstriction | 3 | 1988 | 213 | 0.120 |
Why?
| | Liposomes | 3 | 1997 | 151 | 0.120 |
Why?
| | Triazoles | 2 | 2000 | 134 | 0.120 |
Why?
| | Liver | 2 | 2000 | 1816 | 0.120 |
Why?
| | Perioperative Care | 1 | 2015 | 132 | 0.120 |
Why?
| | Hemolysis | 2 | 1993 | 174 | 0.120 |
Why?
| | Insufflation | 1 | 2013 | 9 | 0.120 |
Why?
| | Serum Albumin | 3 | 1994 | 146 | 0.120 |
Why?
| | Granulocytes | 3 | 1982 | 79 | 0.120 |
Why?
| | Deferoxamine | 2 | 1990 | 17 | 0.120 |
Why?
| | Oligopeptides | 2 | 1992 | 252 | 0.110 |
Why?
| | Smoke | 2 | 2007 | 143 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2674 | 0.110 |
Why?
| | Hypertension, Pulmonary | 5 | 1987 | 1794 | 0.110 |
Why?
| | Molecular Sequence Data | 6 | 1999 | 2871 | 0.110 |
Why?
| | Hydroxyl Radical | 7 | 1991 | 94 | 0.110 |
Why?
| | Pleural Effusion | 4 | 1992 | 47 | 0.110 |
Why?
| | Serpins | 1 | 1992 | 26 | 0.110 |
Why?
| | Sulfhydryl Compounds | 3 | 1992 | 179 | 0.110 |
Why?
| | Glucose Oxidase | 3 | 1987 | 20 | 0.110 |
Why?
| | Microscopy, Electron | 6 | 2000 | 413 | 0.110 |
Why?
| | Tetrazolium Salts | 5 | 1991 | 18 | 0.110 |
Why?
| | Opsonin Proteins | 7 | 1988 | 26 | 0.110 |
Why?
| | Middle Aged | 10 | 2019 | 27617 | 0.100 |
Why?
| | Adult | 22 | 2019 | 31512 | 0.100 |
Why?
| | Acute Lung Injury | 1 | 2015 | 310 | 0.100 |
Why?
| | Disease Susceptibility | 1 | 2014 | 331 | 0.100 |
Why?
| | Respiration | 3 | 2001 | 183 | 0.100 |
Why?
| | Inhalation | 1 | 2011 | 27 | 0.100 |
Why?
| | Cell Hypoxia | 1 | 1992 | 220 | 0.100 |
Why?
| | Brain | 3 | 1992 | 2490 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 2 | 1991 | 509 | 0.100 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 1997 | 67 | 0.100 |
Why?
| | Salmonella typhimurium | 2 | 1991 | 174 | 0.100 |
Why?
| | Melanocytes | 1 | 1991 | 66 | 0.100 |
Why?
| | Muramidase | 3 | 1988 | 72 | 0.100 |
Why?
| | Oxidoreductases | 1 | 1991 | 100 | 0.100 |
Why?
| | Electron Spin Resonance Spectroscopy | 2 | 2008 | 83 | 0.100 |
Why?
| | Phosphorylation | 1 | 2015 | 1633 | 0.100 |
Why?
| | Xenon Isotopes | 2 | 2007 | 3 | 0.100 |
Why?
| | Escherichia coli | 3 | 1988 | 758 | 0.100 |
Why?
| | Fibroblasts | 3 | 1991 | 842 | 0.090 |
Why?
| | Diterpenes | 3 | 1975 | 31 | 0.090 |
Why?
| | Riboflavin | 1 | 1990 | 7 | 0.090 |
Why?
| | Shock | 1 | 1991 | 91 | 0.090 |
Why?
| | Cell Movement | 5 | 1996 | 896 | 0.090 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 942 | 0.090 |
Why?
| | Paraquat | 1 | 1990 | 14 | 0.090 |
Why?
| | Base Sequence | 5 | 1999 | 2159 | 0.090 |
Why?
| | Glycoconjugates | 1 | 1990 | 7 | 0.090 |
Why?
| | Blood Cells | 1 | 1990 | 39 | 0.090 |
Why?
| | Keratinocytes | 1 | 1991 | 227 | 0.090 |
Why?
| | Arachidonic Acids | 1 | 1990 | 57 | 0.090 |
Why?
| | Complement C2 | 3 | 1979 | 6 | 0.090 |
Why?
| | Factor VII | 1 | 1989 | 24 | 0.090 |
Why?
| | Exercise | 1 | 2000 | 1657 | 0.090 |
Why?
| | Hyperbaric Oxygenation | 2 | 1987 | 39 | 0.090 |
Why?
| | Aldehyde Oxidase | 3 | 1999 | 3 | 0.090 |
Why?
| | Reference Values | 4 | 1997 | 774 | 0.090 |
Why?
| | Substrate Specificity | 3 | 1996 | 371 | 0.090 |
Why?
| | RNA | 1 | 1995 | 833 | 0.090 |
Why?
| | Mycobacterium bovis | 3 | 1985 | 11 | 0.090 |
Why?
| | Metals | 1 | 1990 | 111 | 0.090 |
Why?
| | Intestines | 1 | 1992 | 332 | 0.090 |
Why?
| | Alkaline Phosphatase | 3 | 1986 | 157 | 0.090 |
Why?
| | Krypton Radioisotopes | 1 | 2008 | 1 | 0.080 |
Why?
| | Mice | 5 | 2016 | 15520 | 0.080 |
Why?
| | Biological Factors | 1 | 1989 | 41 | 0.080 |
Why?
| | Myocardial Reperfusion | 4 | 1994 | 53 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2005 | 2657 | 0.080 |
Why?
| | Superantigens | 1 | 1988 | 68 | 0.080 |
Why?
| | Enterotoxins | 1 | 1988 | 86 | 0.080 |
Why?
| | Time Factors | 10 | 2000 | 6412 | 0.080 |
Why?
| | Antigens | 2 | 1989 | 320 | 0.080 |
Why?
| | Thromboxane B2 | 2 | 1988 | 27 | 0.080 |
Why?
| | Nitroarginine | 2 | 1999 | 48 | 0.080 |
Why?
| | Blood Pressure | 6 | 1995 | 1664 | 0.080 |
Why?
| | Inhalation Exposure | 1 | 2008 | 87 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 1999 | 2071 | 0.080 |
Why?
| | Nitroprusside | 2 | 1999 | 88 | 0.080 |
Why?
| | Bacterial Toxins | 1 | 1988 | 106 | 0.080 |
Why?
| | Proteins | 5 | 1997 | 938 | 0.080 |
Why?
| | Integrin alpha4beta1 | 1 | 2007 | 7 | 0.080 |
Why?
| | Epithelial Cells | 2 | 2007 | 963 | 0.080 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 35 | 0.080 |
Why?
| | Glomerular Filtration Rate | 4 | 1997 | 683 | 0.080 |
Why?
| | Bronchoalveolar Lavage | 2 | 1998 | 89 | 0.080 |
Why?
| | Creatine Kinase | 3 | 2000 | 75 | 0.080 |
Why?
| | Nylons | 3 | 1984 | 18 | 0.080 |
Why?
| | Phospholipids | 2 | 2000 | 208 | 0.080 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 1994 | 41 | 0.080 |
Why?
| | Alcoholism | 1 | 2014 | 717 | 0.080 |
Why?
| | Image Enhancement | 1 | 2008 | 181 | 0.080 |
Why?
| | Zymosan | 5 | 1990 | 64 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 1999 | 1965 | 0.070 |
Why?
| | Complement Activation | 3 | 1995 | 350 | 0.070 |
Why?
| | Thromboxane A2 | 2 | 1983 | 13 | 0.070 |
Why?
| | Disease | 2 | 2017 | 98 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3174 | 0.070 |
Why?
| | Ischemic Attack, Transient | 1 | 1987 | 62 | 0.070 |
Why?
| | Arginine | 2 | 1998 | 249 | 0.070 |
Why?
| | DNA, Complementary | 2 | 1999 | 268 | 0.070 |
Why?
| | Menstrual Cycle | 1 | 1986 | 113 | 0.070 |
Why?
| | Cytochrome c Group | 3 | 1994 | 37 | 0.070 |
Why?
| | Cell Division | 2 | 1985 | 776 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 2 | 1999 | 372 | 0.070 |
Why?
| | Polymerase Chain Reaction | 3 | 1999 | 1012 | 0.070 |
Why?
| | Contrast Media | 1 | 2008 | 373 | 0.070 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 1985 | 56 | 0.070 |
Why?
| | HEPES | 1 | 1985 | 2 | 0.070 |
Why?
| | Cloning, Molecular | 2 | 1999 | 546 | 0.070 |
Why?
| | Glycoproteins | 1 | 1987 | 319 | 0.070 |
Why?
| | Cerebrovascular Circulation | 1 | 1987 | 204 | 0.070 |
Why?
| | Staphylococcal Infections | 2 | 1986 | 346 | 0.060 |
Why?
| | Agranulocytosis | 2 | 1982 | 31 | 0.060 |
Why?
| | Drug Carriers | 2 | 1997 | 119 | 0.060 |
Why?
| | Purines | 3 | 1998 | 161 | 0.060 |
Why?
| | Isotopes | 3 | 2011 | 26 | 0.060 |
Why?
| | Peroxidases | 2 | 1991 | 29 | 0.060 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2017 | 76 | 0.060 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 1997 | 256 | 0.060 |
Why?
| | Models, Biological | 4 | 2011 | 1715 | 0.060 |
Why?
| | Mesocricetus | 2 | 1995 | 31 | 0.060 |
Why?
| | Aspirin | 2 | 1984 | 334 | 0.060 |
Why?
| | Mannitol | 4 | 1991 | 34 | 0.060 |
Why?
| | Genetic Therapy | 1 | 2005 | 267 | 0.060 |
Why?
| | Enzyme Induction | 1 | 2003 | 94 | 0.060 |
Why?
| | Tuberculoma | 1 | 1983 | 2 | 0.060 |
Why?
| | Lidocaine | 3 | 1987 | 41 | 0.060 |
Why?
| | Cricetinae | 2 | 1995 | 262 | 0.060 |
Why?
| | Iron, Dietary | 1 | 2003 | 19 | 0.060 |
Why?
| | Vasodilator Agents | 2 | 1999 | 328 | 0.060 |
Why?
| | Kidney Diseases | 1 | 1987 | 439 | 0.060 |
Why?
| | Methylprednisolone | 1 | 1983 | 84 | 0.060 |
Why?
| | Osmolar Concentration | 3 | 1994 | 185 | 0.060 |
Why?
| | Tetracaine | 2 | 1979 | 3 | 0.050 |
Why?
| | Carrier Proteins | 2 | 1997 | 726 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2005 | 306 | 0.050 |
Why?
| | Piperazines | 1 | 1985 | 316 | 0.050 |
Why?
| | Cryptococcus | 1 | 1982 | 8 | 0.050 |
Why?
| | Blastomycosis | 2 | 1981 | 9 | 0.050 |
Why?
| | Hematocrit | 3 | 1992 | 91 | 0.050 |
Why?
| | Leukemia, Myeloid | 2 | 1979 | 42 | 0.050 |
Why?
| | Disease Models, Animal | 3 | 1998 | 3730 | 0.050 |
Why?
| | Cryptococcus neoformans | 1 | 1982 | 18 | 0.050 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 1982 | 4 | 0.050 |
Why?
| | Pyelonephritis | 1 | 1982 | 8 | 0.050 |
Why?
| | Chediak-Higashi Syndrome | 2 | 1979 | 7 | 0.050 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1983 | 112 | 0.050 |
Why?
| | Chromatography, Gas | 3 | 1988 | 31 | 0.050 |
Why?
| | Nitrogen Mustard Compounds | 1 | 1981 | 6 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 3 | 1995 | 536 | 0.050 |
Why?
| | Signal Transduction | 1 | 1995 | 4709 | 0.050 |
Why?
| | Environmental Pollution | 1 | 2001 | 18 | 0.050 |
Why?
| | DNA, Superhelical | 1 | 1981 | 11 | 0.050 |
Why?
| | Lasers, Excimer | 1 | 2001 | 21 | 0.050 |
Why?
| | Volatilization | 1 | 2001 | 65 | 0.050 |
Why?
| | Prospective Studies | 3 | 2019 | 6471 | 0.050 |
Why?
| | Complement Pathway, Alternative | 1 | 1982 | 117 | 0.050 |
Why?
| | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1992 | 8 | 0.050 |
Why?
| | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1992 | 12 | 0.050 |
Why?
| | Mycoses | 1 | 1981 | 69 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 4 | 1990 | 196 | 0.050 |
Why?
| | Organ Preservation | 2 | 1991 | 67 | 0.050 |
Why?
| | Urea | 3 | 1990 | 77 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2000 | 30 | 0.050 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2000 | 43 | 0.050 |
Why?
| | Glucose | 8 | 1980 | 953 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 1997 | 1795 | 0.050 |
Why?
| | DNA Primers | 2 | 1999 | 533 | 0.050 |
Why?
| | Ethylenes | 1 | 1979 | 11 | 0.050 |
Why?
| | Azepines | 1 | 2000 | 74 | 0.050 |
Why?
| | Methylurea Compounds | 2 | 1994 | 7 | 0.050 |
Why?
| | Aspartate Aminotransferases | 1 | 2000 | 95 | 0.050 |
Why?
| | Coronary Circulation | 3 | 1991 | 121 | 0.050 |
Why?
| | 6-Aminonicotinamide | 2 | 1990 | 2 | 0.050 |
Why?
| | Hot Temperature | 3 | 1994 | 334 | 0.050 |
Why?
| | Glutathione Reductase | 2 | 1990 | 22 | 0.050 |
Why?
| | Interferon-gamma | 1 | 2003 | 736 | 0.050 |
Why?
| | Chemical Phenomena | 2 | 1995 | 82 | 0.050 |
Why?
| | DNA, Single-Stranded | 1 | 1981 | 114 | 0.040 |
Why?
| | Premedication | 3 | 1985 | 40 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 382 | 0.040 |
Why?
| | Chemotaxis | 2 | 1979 | 137 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2000 | 399 | 0.040 |
Why?
| | Radioimmunoassay | 2 | 1997 | 165 | 0.040 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1999 | 46 | 0.040 |
Why?
| | Bradykinin | 1 | 1999 | 48 | 0.040 |
Why?
| | Cyclic GMP | 1 | 1999 | 109 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 1997 | 510 | 0.040 |
Why?
| | Albumins | 3 | 1991 | 100 | 0.040 |
Why?
| | DNA, Viral | 1 | 1981 | 356 | 0.040 |
Why?
| | Instillation, Drug | 1 | 1998 | 9 | 0.040 |
Why?
| | Gerbillinae | 2 | 1990 | 63 | 0.040 |
Why?
| | Myocardial Infarction | 3 | 1991 | 968 | 0.040 |
Why?
| | Culture Techniques | 2 | 1992 | 80 | 0.040 |
Why?
| | Coculture Techniques | 1 | 1999 | 208 | 0.040 |
Why?
| | Hyperoxia | 1 | 1999 | 97 | 0.040 |
Why?
| | Anesthetics, Local | 1 | 1979 | 85 | 0.040 |
Why?
| | Myocardial Contraction | 3 | 1989 | 339 | 0.040 |
Why?
| | Injections, Intraperitoneal | 1 | 1998 | 108 | 0.040 |
Why?
| | Acetylcholine | 1 | 1999 | 208 | 0.040 |
Why?
| | Pulmonary Ventilation | 2 | 2011 | 71 | 0.040 |
Why?
| | Levamisole | 1 | 1977 | 20 | 0.040 |
Why?
| | Cloning, Organism | 1 | 1997 | 6 | 0.040 |
Why?
| | Oleic Acid | 1 | 1997 | 34 | 0.040 |
Why?
| | Linoleic Acid | 1 | 1997 | 41 | 0.040 |
Why?
| | Aged | 5 | 2019 | 19657 | 0.040 |
Why?
| | Muscle Contraction | 2 | 1990 | 413 | 0.040 |
Why?
| | Phospholipases A2 | 1 | 1997 | 77 | 0.040 |
Why?
| | HIV Infections | 1 | 1992 | 2459 | 0.040 |
Why?
| | Electron Transport | 2 | 1995 | 101 | 0.040 |
Why?
| | Methane | 3 | 1983 | 43 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2001 | 482 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1990 | 490 | 0.040 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1997 | 26 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 2017 | 173 | 0.040 |
Why?
| | NADP | 2 | 1988 | 50 | 0.040 |
Why?
| | Absorption | 1 | 1997 | 56 | 0.040 |
Why?
| | Complement System Proteins | 2 | 1977 | 294 | 0.040 |
Why?
| | Tumor Necrosis Factor Decoy Receptors | 1 | 1996 | 8 | 0.040 |
Why?
| | Benzamidines | 1 | 1996 | 3 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1284 | 0.040 |
Why?
| | Isoelectric Point | 1 | 1996 | 23 | 0.040 |
Why?
| | Injury Severity Score | 1 | 1999 | 528 | 0.040 |
Why?
| | Hydrolysis | 1 | 1997 | 176 | 0.040 |
Why?
| | Xanthines | 1 | 1996 | 15 | 0.040 |
Why?
| | Immunoassay | 1 | 1997 | 101 | 0.040 |
Why?
| | Sepharose | 1 | 1996 | 33 | 0.040 |
Why?
| | Adenine | 2 | 1997 | 223 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 1996 | 79 | 0.040 |
Why?
| | Endocarditis, Bacterial | 1 | 1976 | 37 | 0.040 |
Why?
| | Sodium Chloride | 2 | 1990 | 144 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 1998 | 736 | 0.030 |
Why?
| | Interleukin-4 | 1 | 1997 | 215 | 0.030 |
Why?
| | Diet | 4 | 1995 | 1153 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2003 | 1753 | 0.030 |
Why?
| | Cathepsin G | 1 | 1995 | 6 | 0.030 |
Why?
| | Cathepsins | 1 | 1995 | 22 | 0.030 |
Why?
| | Chemistry, Physical | 1 | 1995 | 40 | 0.030 |
Why?
| | Injections | 1 | 1996 | 167 | 0.030 |
Why?
| | Cell Separation | 1 | 1997 | 296 | 0.030 |
Why?
| | Hydrochloric Acid | 1 | 1995 | 8 | 0.030 |
Why?
| | Sex Chromosomes | 1 | 1975 | 48 | 0.030 |
Why?
| | Cross Reactions | 1 | 1995 | 116 | 0.030 |
Why?
| | Factor VIII | 2 | 1993 | 56 | 0.030 |
Why?
| | Single-Blind Method | 1 | 1996 | 269 | 0.030 |
Why?
| | Isoenzymes | 1 | 1996 | 297 | 0.030 |
Why?
| | Adolescent | 8 | 1999 | 18480 | 0.030 |
Why?
| | Injections, Spinal | 1 | 1995 | 105 | 0.030 |
Why?
| | ROC Curve | 1 | 1997 | 473 | 0.030 |
Why?
| | Erythrocyte Indices | 1 | 1995 | 29 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1995 | 105 | 0.030 |
Why?
| | United States | 1 | 2011 | 12555 | 0.030 |
Why?
| | Acyltransferases | 1 | 1995 | 53 | 0.030 |
Why?
| | Uteroglobin | 1 | 2014 | 16 | 0.030 |
Why?
| | Cytosol | 1 | 1995 | 221 | 0.030 |
Why?
| | Tuberculosis, Pleural | 2 | 1985 | 6 | 0.030 |
Why?
| | Croton Oil | 1 | 1974 | 2 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 1997 | 360 | 0.030 |
Why?
| | Hydroxyurea | 1 | 1994 | 30 | 0.030 |
Why?
| | Drug Tolerance | 1 | 1994 | 78 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1994 | 36 | 0.030 |
Why?
| | Leukotriene Antagonists | 1 | 1994 | 40 | 0.030 |
Why?
| | Ficoll | 1 | 1994 | 5 | 0.030 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 1995 | 62 | 0.030 |
Why?
| | Nitrites | 1 | 2014 | 81 | 0.030 |
Why?
| | Drug Combinations | 1 | 1995 | 291 | 0.030 |
Why?
| | Anions | 3 | 1995 | 31 | 0.030 |
Why?
| | Serum Albumin, Radio-Iodinated | 1 | 1994 | 6 | 0.030 |
Why?
| | Methods | 2 | 1984 | 67 | 0.030 |
Why?
| | Breath Tests | 1 | 1994 | 89 | 0.030 |
Why?
| | Dogs | 6 | 1991 | 371 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 76 | 0.030 |
Why?
| | Enzyme Activation | 3 | 1991 | 828 | 0.030 |
Why?
| | Apoptosis | 1 | 2003 | 2484 | 0.030 |
Why?
| | Pressure | 2 | 1986 | 226 | 0.030 |
Why?
| | Stomach | 1 | 1994 | 103 | 0.030 |
Why?
| | Diptera | 1 | 1993 | 29 | 0.030 |
Why?
| | Haploidy | 1 | 1993 | 21 | 0.030 |
Why?
| | Clinical Enzyme Tests | 1 | 1993 | 11 | 0.030 |
Why?
| | Genes | 1 | 1993 | 231 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1993 | 336 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 1994 | 251 | 0.030 |
Why?
| | Epoprostenol | 2 | 1991 | 132 | 0.030 |
Why?
| | Platelet Count | 2 | 1984 | 83 | 0.030 |
Why?
| | Hemoglobins | 1 | 1995 | 326 | 0.030 |
Why?
| | Shock, Hemorrhagic | 1 | 1995 | 206 | 0.030 |
Why?
| | Biomechanical Phenomena | 2 | 1987 | 683 | 0.030 |
Why?
| | Drosophila | 1 | 1993 | 140 | 0.030 |
Why?
| | Chromium | 1 | 1992 | 12 | 0.030 |
Why?
| | Survival Rate | 1 | 1997 | 1720 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 1992 | 210 | 0.030 |
Why?
| | NF-kappa B | 1 | 1996 | 670 | 0.030 |
Why?
| | Indoles | 1 | 1994 | 316 | 0.030 |
Why?
| | Glucosephosphates | 1 | 1991 | 3 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2874 | 0.030 |
Why?
| | Glucose-6-Phosphate | 1 | 1991 | 6 | 0.030 |
Why?
| | Elapid Venoms | 1 | 1991 | 16 | 0.030 |
Why?
| | Disease Progression | 1 | 1999 | 2490 | 0.030 |
Why?
| | Double-Blind Method | 1 | 1996 | 1687 | 0.030 |
Why?
| | Gene Expression | 2 | 1995 | 1489 | 0.030 |
Why?
| | Mechlorethamine | 2 | 1982 | 58 | 0.030 |
Why?
| | Ethylmaleimide | 2 | 1989 | 18 | 0.030 |
Why?
| | Pentetic Acid | 1 | 1991 | 12 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 1995 | 788 | 0.020 |
Why?
| | Formaldehyde | 1 | 1991 | 50 | 0.020 |
Why?
| | Sodium Azide | 1 | 1990 | 6 | 0.020 |
Why?
| | Ventricular Function | 1 | 1991 | 60 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2000 | 1515 | 0.020 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2014 | 247 | 0.020 |
Why?
| | Azides | 1 | 1990 | 47 | 0.020 |
Why?
| | Alcohols | 3 | 1975 | 31 | 0.020 |
Why?
| | Edetic Acid | 1 | 1990 | 47 | 0.020 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1992 | 224 | 0.020 |
Why?
| | Guinea Pigs | 1 | 1990 | 151 | 0.020 |
Why?
| | Arteries | 2 | 1988 | 250 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 1990 | 149 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1990 | 119 | 0.020 |
Why?
| | Methionine | 1 | 1990 | 145 | 0.020 |
Why?
| | Enzyme Stability | 2 | 2005 | 75 | 0.020 |
Why?
| | Streptococcus pneumoniae | 2 | 1981 | 141 | 0.020 |
Why?
| | Body Weight | 1 | 1994 | 934 | 0.020 |
Why?
| | Catalysis | 1 | 1990 | 295 | 0.020 |
Why?
| | Heart Arrest, Induced | 1 | 1989 | 32 | 0.020 |
Why?
| | Cell Survival | 2 | 1990 | 1047 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1992 | 1293 | 0.020 |
Why?
| | Carmustine | 1 | 1988 | 47 | 0.020 |
Why?
| | Epithelium | 1 | 1990 | 305 | 0.020 |
Why?
| | Pentose Phosphate Pathway | 1 | 1988 | 44 | 0.020 |
Why?
| | Prognosis | 1 | 1997 | 3443 | 0.020 |
Why?
| | Biological Assay | 2 | 1981 | 122 | 0.020 |
Why?
| | Campylobacter fetus | 1 | 1988 | 1 | 0.020 |
Why?
| | Protamines | 1 | 1988 | 5 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1996 | 772 | 0.020 |
Why?
| | Campylobacter Infections | 1 | 1988 | 9 | 0.020 |
Why?
| | Temperature | 2 | 1983 | 622 | 0.020 |
Why?
| | Interleukin-2 | 1 | 1989 | 416 | 0.020 |
Why?
| | Papaverine | 1 | 1987 | 2 | 0.020 |
Why?
| | Microbial Collagenase | 1 | 1987 | 10 | 0.020 |
Why?
| | Antimycin A | 2 | 1995 | 13 | 0.020 |
Why?
| | Organ Specificity | 1 | 1988 | 278 | 0.020 |
Why?
| | Helium | 1 | 2007 | 8 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 42 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2007 | 32 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 1986 | 4596 | 0.020 |
Why?
| | Nicotine | 1 | 1990 | 276 | 0.020 |
Why?
| | Constriction | 1 | 1987 | 46 | 0.020 |
Why?
| | Hemiplegia | 1 | 1987 | 19 | 0.020 |
Why?
| | Membranes | 1 | 1987 | 17 | 0.020 |
Why?
| | Fatty Acids | 3 | 1975 | 407 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 113 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 332 | 0.020 |
Why?
| | Complement C3 | 1 | 1988 | 192 | 0.020 |
Why?
| | Heart Ventricles | 2 | 1989 | 727 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2007 | 139 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 1988 | 418 | 0.020 |
Why?
| | Brain Ischemia | 1 | 1990 | 310 | 0.020 |
Why?
| | Carboxypeptidases | 1 | 1985 | 14 | 0.020 |
Why?
| | Drug Synergism | 1 | 1986 | 339 | 0.020 |
Why?
| | Carotid Arteries | 1 | 1987 | 184 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 1985 | 31 | 0.020 |
Why?
| | Surface Properties | 1 | 2007 | 397 | 0.020 |
Why?
| | Sneezing | 1 | 1985 | 1 | 0.020 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2005 | 101 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 1987 | 439 | 0.020 |
Why?
| | Lipid Peroxides | 1 | 1985 | 8 | 0.020 |
Why?
| | Granuloma | 1 | 1985 | 87 | 0.020 |
Why?
| | Sheep | 2 | 1988 | 764 | 0.020 |
Why?
| | Cell Communication | 1 | 1987 | 281 | 0.020 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1985 | 31 | 0.020 |
Why?
| | Hemodynamics | 4 | 1991 | 1003 | 0.020 |
Why?
| | Blood Glucose | 4 | 1983 | 1939 | 0.020 |
Why?
| | Blotting, Western | 1 | 2007 | 1194 | 0.020 |
Why?
| | Rheology | 1 | 1985 | 87 | 0.020 |
Why?
| | Mucous Membrane | 1 | 1985 | 113 | 0.020 |
Why?
| | Cough | 1 | 1985 | 102 | 0.020 |
Why?
| | Cyanamide | 1 | 1983 | 1 | 0.020 |
Why?
| | Pleurisy | 1 | 1983 | 6 | 0.020 |
Why?
| | Singlet Oxygen | 1 | 1984 | 19 | 0.020 |
Why?
| | Radiation Injuries, Experimental | 1 | 1983 | 24 | 0.010 |
Why?
| | Respiratory System | 1 | 1985 | 141 | 0.010 |
Why?
| | Behavior, Animal | 1 | 1987 | 486 | 0.010 |
Why?
| | Dietary Proteins | 1 | 1985 | 130 | 0.010 |
Why?
| | Bacteria | 2 | 1981 | 757 | 0.010 |
Why?
| | Molecular Weight | 1 | 1983 | 343 | 0.010 |
Why?
| | BCG Vaccine | 1 | 1983 | 25 | 0.010 |
Why?
| | Prostanoic Acids | 1 | 1983 | 1 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1986 | 266 | 0.010 |
Why?
| | Pulmonary Fibrosis | 1 | 1986 | 303 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 2005 | 238 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1691 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1985 | 270 | 0.010 |
Why?
| | Macrophage Activation | 1 | 1984 | 168 | 0.010 |
Why?
| | Immunization | 1 | 1985 | 412 | 0.010 |
Why?
| | Mammals | 1 | 1985 | 253 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2005 | 749 | 0.010 |
Why?
| | Mice, Inbred BALB C | 2 | 1996 | 1206 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1982 | 15 | 0.010 |
Why?
| | Dietary Fats | 1 | 1985 | 322 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1982 | 24 | 0.010 |
Why?
| | Serum Albumin, Bovine | 1 | 1982 | 67 | 0.010 |
Why?
| | Stimulation, Chemical | 2 | 1978 | 59 | 0.010 |
Why?
| | Pulmonary Veins | 1 | 1982 | 84 | 0.010 |
Why?
| | Leukocyte Adherence Inhibition Test | 1 | 1981 | 1 | 0.010 |
Why?
| | Imidazoles | 1 | 1983 | 232 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1983 | 397 | 0.010 |
Why?
| | Histoplasmosis | 1 | 1981 | 15 | 0.010 |
Why?
| | Vacuoles | 2 | 1978 | 33 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 1981 | 60 | 0.010 |
Why?
| | Enterococcus faecalis | 2 | 1979 | 24 | 0.010 |
Why?
| | Skin Tests | 1 | 1981 | 135 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1981 | 204 | 0.010 |
Why?
| | Ethane | 1 | 1979 | 2 | 0.010 |
Why?
| | Hexosephosphates | 1 | 1979 | 5 | 0.010 |
Why?
| | Bacteriolysis | 1 | 1979 | 9 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 1983 | 465 | 0.010 |
Why?
| | Keto Acids | 1 | 1979 | 13 | 0.010 |
Why?
| | Ferrous Compounds | 1 | 1979 | 23 | 0.010 |
Why?
| | Peroxides | 1 | 1979 | 21 | 0.010 |
Why?
| | Chemistry | 1 | 1979 | 39 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1979 | 23 | 0.010 |
Why?
| | Butyrates | 1 | 1979 | 54 | 0.010 |
Why?
| | Anesthesia, Local | 1 | 1979 | 17 | 0.010 |
Why?
| | Electromagnetic Phenomena | 1 | 1979 | 23 | 0.010 |
Why?
| | Aldehydes | 1 | 1979 | 154 | 0.010 |
Why?
| | Blastomyces | 1 | 1978 | 8 | 0.010 |
Why?
| | Immune Sera | 1 | 1978 | 82 | 0.010 |
Why?
| | Heterozygote | 1 | 1979 | 262 | 0.010 |
Why?
| | Cell Membrane | 2 | 1978 | 710 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1982 | 1384 | 0.010 |
Why?
| | Glycolysis | 1 | 1978 | 224 | 0.010 |
Why?
| | Species Specificity | 1 | 1978 | 565 | 0.010 |
Why?
| | Bronchoscopy | 1 | 1979 | 247 | 0.010 |
Why?
| | Hypergammaglobulinemia | 1 | 1976 | 9 | 0.010 |
Why?
| | Phenylbutazone | 1 | 1976 | 2 | 0.010 |
Why?
| | Leucine Zippers | 1 | 1996 | 16 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1996 | 53 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 34 | 0.010 |
Why?
| | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1995 | 4 | 0.010 |
Why?
| | Syndrome | 1 | 1976 | 344 | 0.010 |
Why?
| | Eczema | 1 | 1976 | 85 | 0.010 |
Why?
| | Mitochondria, Liver | 1 | 1995 | 70 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1975 | 75 | 0.010 |
Why?
| | Platelet Aggregation | 1 | 1975 | 97 | 0.010 |
Why?
| | Protons | 1 | 1995 | 79 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1975 | 96 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1995 | 73 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1995 | 130 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 1976 | 365 | 0.010 |
Why?
| | Carbon Radioisotopes | 1 | 1974 | 45 | 0.010 |
Why?
| | Inclusion Bodies | 1 | 1974 | 25 | 0.010 |
Why?
| | Coloring Agents | 1 | 1974 | 73 | 0.010 |
Why?
| | Spleen | 1 | 1996 | 510 | 0.010 |
Why?
| | Staphylococcus | 1 | 1974 | 68 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1994 | 245 | 0.010 |
Why?
| | Vascular Diseases | 1 | 1975 | 241 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 76 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1996 | 597 | 0.010 |
Why?
| | Solutions | 1 | 1991 | 156 | 0.010 |
Why?
| | Blood | 1 | 1991 | 100 | 0.010 |
Why?
| | Cold Temperature | 1 | 1991 | 132 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 146 | 0.010 |
Why?
| | Insulin | 1 | 1980 | 2162 | 0.010 |
Why?
| | Nitroglycerin | 1 | 1990 | 24 | 0.010 |
Why?
| | Half-Life | 1 | 1989 | 147 | 0.010 |
Why?
| | Child | 2 | 1979 | 19129 | 0.010 |
Why?
| | Blood Gas Analysis | 1 | 1989 | 69 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 1996 | 1346 | 0.010 |
Why?
| | Complement C9 | 1 | 1988 | 5 | 0.010 |
Why?
| | Microspheres | 1 | 1989 | 130 | 0.010 |
Why?
| | Fluoresceins | 1 | 1988 | 47 | 0.010 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 1988 | 38 | 0.010 |
Why?
| | Complement C5 | 1 | 1988 | 75 | 0.010 |
Why?
| | Thiocyanates | 1 | 1988 | 29 | 0.010 |
Why?
| | Coronary Vessels | 1 | 1990 | 233 | 0.010 |
Why?
| | Phenotype | 1 | 1976 | 3003 | 0.010 |
Why?
| | Quinidine | 1 | 1987 | 6 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 5 | 0.000 |
Why?
| | Virulence | 1 | 1988 | 240 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1976 | 1510 | 0.000 |
Why?
| | Heparin | 1 | 1988 | 230 | 0.000 |
Why?
| | Fluorescent Dyes | 1 | 1988 | 316 | 0.000 |
Why?
| | Aorta, Thoracic | 1 | 1988 | 248 | 0.000 |
Why?
| | Swine | 1 | 1988 | 730 | 0.000 |
Why?
| | Stroke Volume | 1 | 1988 | 512 | 0.000 |
Why?
| | Pleura | 1 | 1983 | 18 | 0.000 |
Why?
| | Micropore Filters | 1 | 1982 | 6 | 0.000 |
Why?
| | Cytochalasin B | 1 | 1982 | 17 | 0.000 |
Why?
| | Transducers, Pressure | 1 | 1982 | 15 | 0.000 |
Why?
| | Ultrafiltration | 1 | 1982 | 28 | 0.000 |
Why?
| | Polysaccharides, Bacterial | 1 | 1981 | 69 | 0.000 |
Why?
| | Tritium | 1 | 1980 | 70 | 0.000 |
Why?
| | Cytoplasmic Granules | 1 | 1979 | 84 | 0.000 |
Why?
| | Microvilli | 1 | 1978 | 70 | 0.000 |
Why?
| | Myristates | 1 | 1977 | 1 | 0.000 |
Why?
| | Histocompatibility Testing | 1 | 1975 | 123 | 0.000 |
Why?
|
|
Repine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|